WO2023073606 - A PROCESS FOR PREPARATION OF INTERMEDIATE OF EDOXABAN
National phase entry is expected:
Publication Number
WO/2023/073606
Publication Date
04.05.2023
International Application No.
PCT/IB2022/060338
International Filing Date
27.10.2022
Title **
[English]
A PROCESS FOR PREPARATION OF INTERMEDIATE OF EDOXABAN
[French]
PROCÉDÉ DE PRÉPARATION D'UN INTERMÉDIAIRE D'ÉDOXABAN
Applicants **
PIRAMAL PHARMA LIMITED
Inventors
JAGTAP, Ashutosh
SINORE, Sandip
MARATHE, Suyog
LADKAT, Prashant
KANSAGARA, Nainesh
Priority Data
202121049060
27.10.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1955 | |
| EPO | Filing, Examination, Granting | 11598 | |
| Japan | Filing, Examination, Granting | 1983 | |
| South Korea | Filing, Examination, Granting | 1731 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,007
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to an industrially feasible and economically viable process for preparation of Edoxaban key intermediate viz. compound of formula (1) which is shown below:[French]
La présente invention concerne un procédé industriellement réalisable et économiquement viable pour la préparation d'un intermédiaire clé d'édoxaban, à savoir, un composé de formule (1) qui est représenté ci-dessous :